相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Can Population Pharmacokinetics of Antibiotics be Extrapolated? Implications of External Evaluations
Yu Cheng et al.
CLINICAL PHARMACOKINETICS (2021)
Predictive ability of published population pharmacokinetic models of valproic acid in Thai manic patients
Janthima Methaneethorn et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2021)
Antibiotics in Adult Cystic Fibrosis Patients: A Review of Population Pharmacokinetic Analyses
Mehdi El Hassani et al.
CLINICAL PHARMACOKINETICS (2021)
Amikacin nomogram for treatment of adult cystic fibrosis exacerbations based on an external evaluation of a population pharmacokinetic model
Daniel J. G. Thirion et al.
PEDIATRIC PULMONOLOGY (2020)
Aminoglycosides in critically ill patients: which dosing regimens for which pathogens?
A. Marsot et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Optimizing Estimated Glomerular Filtration Rate to Support Adult to Pediatric Pharmacokinetic Bridging Studies in Patients with Cystic Fibrosis
Ryan L. Crass et al.
CLINICAL PHARMACOKINETICS (2019)
Pharmacokinetic/pharmacodynamic analysis of weight- and height-scaled tobramycin dosage regimens for patients with cystic fibrosis
S. S. Alghanem et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Augmented Renal Clearance in Critically Ill Patients: A Systematic Review
Idoia Bilbao-Meseguer et al.
CLINICAL PHARMACOKINETICS (2018)
External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients
Jun-Jun Mao et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Assessing the accuracy of predictive models for numerical data: Not r nor r2, why not? Then what?
Jin Li
PLOS ONE (2017)
Predictive performance of eleven pharmacokinetic models for propofol infusion in children for long-duration anaesthesia
M. Hara et al.
BRITISH JOURNAL OF ANAESTHESIA (2017)
Pharmacokinetic and pharmacodynamic optimisation of intravenous tobramycin dosing among children with cystic fibrosis
Catherine M. T. Sherwin et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2014)
Population Pharmacokinetics of Tobramycin in Patients With and Without Cystic Fibrosis
Stefanie Hennig et al.
CLINICAL PHARMACOKINETICS (2013)
Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis
Sarah Alghanem et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Evaluation of the predictive performance of a pharmacokinetic model for propofol in Japanese macaques (Macaca fuscata fuscata)
T. Miyabe-Nishiwaki et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2013)
Therapeutic drug monitoring of antimicrobials
Jason A. Roberts et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Cystic fibrosis: Insight into CFTR pathophysiology and pharmacotherapy
Bob Lubamba et al.
CLINICAL BIOCHEMISTRY (2012)
Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
Martin Bergstrand et al.
AAPS JOURNAL (2011)
Renal dysfunction in chronic liver disease
Andy Slack et al.
CRITICAL CARE (2010)
Cystic Fibrosis Pulmonary Guidelines Treatment of Pulmonary Exacerbations
Patrick A. Flume et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis - a population pharmacokinetic study
Stefanie Hennig et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Effect of malnutrition on serum creatinine and cystatin C levels
Pankaj Hari et al.
PEDIATRIC NEPHROLOGY (2007)
Population pharmacokinetics of tobramycin administered thrice daily and once daily in children and adults with cystic fibrosis
D. J. Touw et al.
JOURNAL OF CYSTIC FIBROSIS (2007)
Pharmacokinetic profile of once daily intravenous tobramycin in children with cystic fibrosis
John Massie et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2006)
Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide
Karl Brendel et al.
PHARMACEUTICAL RESEARCH (2006)
Assessment of the validity of a population pharmacokinetic model for epirubicin
Lorraine D. Ralph et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis - the TOPIC study: a randomised controlled trial
A Smyth et al.
LANCET (2005)
Pharmacokinetics of tobramycin in adults with cystic fibrosis: Implications for once-daily administration
PM Beringer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
